| ANUSOL PLUS OINTMENT (1 %)Church & Dwight Canada Corp. · Status since Mar 2017 | 01945912 | Marketed | Church & Dwight Canada Corp. | Mar 2017 |
| ANUSOL PLUS SUPPOSITORIES (20 MG)Church & Dwight Canada Corp. · Status since Mar 2017 | 01945904 | Marketed | Church & Dwight Canada Corp. | Mar 2017 |
| AVEENO ANTI-ITCH LOTION (1 %)Kenvue Canada Inc. · Status since Mar 2026 | 02240105 | Marketed | Kenvue Canada Inc. | Mar 2026 |
| GOLD BOND ANTI-ITCH LOTION (1 %)Sanofi Consumer Health Inc · Status since Nov 2011 | 02318482 | Marketed | Sanofi Consumer Health Inc | Nov 2011 |
| GOLD BOND MEDICATED ANTI-ITCH CREAM (1 %)Sanofi Consumer Health Inc · Status since Dec 2011 | 02236991 | Marketed | Sanofi Consumer Health Inc | Dec 2011 |
| ITCH RELIEF MOISTURIZING CREAM (1 %)Cerave Canada · Status since Feb 2021 | 02484889 | Marketed | Cerave Canada | Feb 2021 |
| ITCH RELIEF MOISTURIZING LOTION (1 %)Cerave Canada · Status since Feb 2021 | 02486881 | Marketed | Cerave Canada | Feb 2021 |
| POLYSPORIN ITCH RELIEF (1 %)Kenvue Canada Inc. · Status since Mar 2026 | 02246156 | Marketed | Kenvue Canada Inc. | Mar 2026 |
| PRAMOX HC CREAM (1 %)Dermtek Pharma Inc. · Status since Dec 1989 | 00770957 | Marketed | Dermtek Pharma Inc. | Dec 1989 |
| PRAMOX HC LOTION (1 %)Dermtek Pharma Inc. · Status since Dec 1994 | 01954210 | Marketed | Dermtek Pharma Inc. | Dec 1994 |
| PROCTODAN-HC OINTMENT (1 %)Odan Laboratoriesltd · Status since Jan 1998 | 02234466 | Marketed | Odan Laboratoriesltd | Jan 1998 |
| PROCTODAN-HC SUPPOSITORIES (20 MG)Odan Laboratoriesltd · Status since Mar 2000 | 02240851 | Marketed | Odan Laboratoriesltd | Mar 2000 |
| ANODAN-PLUS (20 MG)Odan Laboratoriesltd · Status since Jan 2016 | 02450801 | Approved | Odan Laboratoriesltd | Jan 2016 |
| ANODAN-PLUS OINTMENT (1 %)Odan Laboratoriesltd · Status since Mar 2016 | 02453185 | Approved | Odan Laboratoriesltd | Mar 2016 |
| ANUZINC HC PLUS (20 MG)Laboratoires Confab Inc. · Status since Jul 2021 | 02242797 | Dormant | Laboratoires Confab Inc. | Jul 2021 |
| HEMORRHOID OINTMENT (1 %)JAMP Pharma Corporation · Status since Aug 2017 | 02251981 | Dormant | JAMP Pharma Corporation | Aug 2017 |
| HEMORRHOIDAL OINTMENT WITH ANESTHETIC FOR EXTRA PAIN RELIEF (1 %)CellChem Pharmaceuticals Inc. · Status since Jan 2020 | 02295865 | Approved | CellChem Pharmaceuticals Inc. | Jan 2020 |
| ITCH RELIEF LOTION (1 %)CellChem Pharmaceuticals Inc. · Status since Jan 2021 | 02510820 | Approved | CellChem Pharmaceuticals Inc. | Jan 2021 |
| PREPARATION H CREAM (1 %)Haleon Canada ULC · Status since Oct 2025 | 02562243 | Approved | Haleon Canada ULC | Oct 2025 |
| PROCTOFOAM-HC (1 %)Duchesnay Inc. · Status since Jul 2023 | 00363014 | Dormant | Duchesnay Inc. | Jul 2023 |
| SARNA CALM + COOL ANTI-ITCH LOTION (1 %)Crown Laboratories, Inc. · Status since Aug 2024 | 02550563 | Approved | Crown Laboratories, Inc. | Aug 2024 |
| SARNA SENSITIVE ANTI-ITCH LOTION (1 %)Crown Laboratories, Inc. · Status since Sep 2024 | 02552191 | Approved | Crown Laboratories, Inc. | Sep 2024 |
| TUCKS TRIPLE RELIEF HEMORRHOIDAL CREAM (1 %)Blistex Corporation · Status since Oct 2026 | 02572346 | Approved | Blistex Corporation | Oct 2026 |
| ANUGESIC-HC OINTMENT (1 %)McNeil Consumer Healthcare, division of Johnson & Johnson Inc. · Status since Feb 2021 | 00505781 | Cancelled Post Market | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Feb 2021 |
| ANUGESIC-HC SUPPOSITORIES (20 MG)McNeil Consumer Healthcare, division of Johnson & Johnson Inc. · Status since Aug 2020 | 00476242 | Cancelled Post Market | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Aug 2020 |
| ANUZINC PLUS SUPPOSITORIES (20 MG)Sabex Inc. · Status since Aug 2008 | 02248425 | Cancelled Post Market | Sabex Inc. | Aug 2008 |
| AVEENO ANTI-ITCH CREAM (1 %)S.C. Johnson and Son Limited · Status since Sep 1996 | 02068176 | Cancelled Post Market | S.C. Johnson and Son Limited | Sep 1996 |
| AVEENO ANTI-ITCH CREAM (1 %)S.C. Johnson and Son Limited · Status since Jul 2000 | 02153653 | Cancelled Post Market | S.C. Johnson and Son Limited | Jul 2000 |
| AVEENO ANTI-ITCH CREAM (1.0 %)Johnson & Johnson Inc · Status since Jul 2014 | 02240104 | Cancelled Post Market | Johnson & Johnson Inc | Jul 2014 |
| AVEENO ANTI-ITCH LOTION (1 %)S.C. Johnson and Son Limited · Status since Sep 1996 | 02068168 | Cancelled Post Market | S.C. Johnson and Son Limited | Sep 1996 |
| AVEENO ANTI-ITCH LOTION (1 %)S.C. Johnson and Son Limited · Status since Jul 2000 | 02153645 | Cancelled Post Market | S.C. Johnson and Son Limited | Jul 2000 |
| BACTINE PAIN RELIEVING CLEANSING SPRAY (1 %)Bayer Inc Consumer Care · Status since Aug 2017 | 02247638 | Cancelled Pre Market | Bayer Inc Consumer Care | Aug 2017 |
| BIKINI ZONE MEDICATED AFTER SHAVE SPRAY (1 %)CCA Industries Inc · Status since Aug 2017 | 02420074 | Cancelled Pre Market | CCA Industries Inc | Aug 2017 |
| BIKINI ZONE MEDICATED AFTER-SHAVE ROLL-ON RELIEF (1 %)CCA Industries Inc · Status since Aug 2017 | 02374927 | Cancelled Pre Market | CCA Industries Inc | Aug 2017 |
| CALADRYL CREAM (1 %)Warner-Lambert Canada Inc. · Status since Aug 2017 | 02238743 | Cancelled Pre Market | Warner-Lambert Canada Inc. | Aug 2017 |
| CALADRYL LOTION (1 %)Johnson & Johnson Inc · Status since Aug 2010 | 02238744 | Cancelled Post Market | Johnson & Johnson Inc | Aug 2010 |
| CLEAR ANTI-ITCH LOTION (1 %)Perrigo International, Inc. · Status since Mar 2001 | 02230493 | Cancelled Post Market | Perrigo International, Inc. | Mar 2001 |
| CLEAR ANTI-ITCH LOTION (1.0 %)Lander Co. Canada Limited · Status since Oct 2008 | 02244180 | Cancelled Post Market | Lander Co. Canada Limited | Oct 2008 |
| DERMOPLAST POISON IVY TREATMENT (1 %)Medtech Products, Inc. · Status since Mar 2014 | 02287358 | Cancelled Post Market | Medtech Products, Inc. | Mar 2014 |
| EXTRA STRENGTH BACITRAYCIN PLUS (1 %)First Aid Research Corporation · Status since Jan 2023 | 02283328 | Cancelled (Unreturned Annual) | First Aid Research Corporation | Jan 2023 |
| FIRST ON TOPICAL ANALGESIC (1.0 %)Arvidis, Inc. · Status since Jan 2009 | 02295555 | Cancelled Post Market | Arvidis, Inc. | Jan 2009 |
| FISSURENE (1 %)Ferndale Laboratories Inc. · Status since Apr 2018 | 02260085 | Cancelled (Unreturned Annual) | Ferndale Laboratories Inc. | Apr 2018 |
| HEMORRHOID OINTMENT (1 %)Stanley Pharmaceuticals, A Division Of Vita Health Products Inc. · Status since Jul 2002 | 02229647 | Cancelled Post Market | Stanley Pharmaceuticals, A Division Of Vita Health Products Inc. | Jul 2002 |
| HEMORRHOIDAL OINTMENT (1.0 %)Pharmascience Inc. · Status since Feb 2020 | 02218887 | Cancelled Post Market | Pharmascience Inc. | Feb 2020 |
| HEMORRHOIDAL OINTMENT (1 %)Pharmascience Inc. · Status since Jul 2025 | 02248891 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| ITCH RELIEF BALM (0.5 %)Johnson & Johnson Inc · Status since Jan 2023 | 02486385 | Cancelled Post Market | Johnson & Johnson Inc | Jan 2023 |
| ITCH RELIEF LOTION (1.0 %)Crls · Status since Mar 2022 | 02318423 | Cancelled Post Market | Crls | Mar 2022 |
| ITCH X GEL (1 %)B.F. Ascher & Company Inc. · Status since Jul 1998 | 02049074 | Cancelled Post Market | B.F. Ascher & Company Inc. | Jul 1998 |
| ITCH-X GEL (1 %)B.F. Ascher & Company Inc. · Status since Jul 2002 | 02186918 | Cancelled Post Market | B.F. Ascher & Company Inc. | Jul 2002 |
| MEDICATED CALAMINE LOTION WITH PRAMOXINE HCL (1 %)Perrigo International, Inc. · Status since Mar 2001 | 02230683 | Cancelled Post Market | Perrigo International, Inc. | Mar 2001 |
| NO MORE BUMPS (1 %)Del Pharmaceutics (Canada) Inc. · Status since Nov 2009 | 02280027 | Cancelled Post Market | Del Pharmaceutics (Canada) Inc. | Nov 2009 |
| POLYSPORIN LIP TREATMENT (1 %)Johnson & Johnson Inc · Status since Jul 2014 | 02266881 | Cancelled Post Market | Johnson & Johnson Inc | Jul 2014 |
| POLYSPORIN POLY TO GO (1 %)Johnson & Johnson Inc · Status since Feb 2021 | 02318946 | Cancelled Post Market | Johnson & Johnson Inc | Feb 2021 |
| PRAMEGEL (1.0 %)Valeant Canada Lp · Status since Jul 2014 | 00740284 | Cancelled Post Market | Valeant Canada Lp | Jul 2014 |
| PRO-RELIEF (1 %)Blistex Corporation · Status since Jul 2007 | 02248904 | Cancelled Post Market | Blistex Corporation | Jul 2007 |
| SANDOZ ANUZINC HC PLUS (10 MG)Sandoz Canada Inc. · Status since Aug 2017 | 02247692 | Cancelled Post Market | Sandoz Canada Inc. | Aug 2017 |
| SANDOZ ANUZINC PLUS (10 MG)Sandoz Canada Inc. · Status since Aug 2017 | 02248424 | Cancelled Post Market | Sandoz Canada Inc. | Aug 2017 |
| SARNA P (1 %)Glaxosmithkline Inc · Status since Aug 2012 | 00874825 | Cancelled Post Market | Glaxosmithkline Inc | Aug 2012 |
| SKIN RELIEF MEDICATED ANTI-ITCH TREATMENT (0.5 %)Johnson & Johnson Inc · Status since Jul 2014 | 02369702 | Cancelled Post Market | Johnson & Johnson Inc | Jul 2014 |
| SOOTHING CARE ITCH RELIEF SPRAY (1 %)McNeil Consumer Healthcare, division of Johnson & Johnson Inc. · Status since Jan 2016 | 02273926 | Cancelled Pre Market | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Jan 2016 |
| TRONOTHANE PRAMOXINE HCL CRM 1% USP (1 %)Abbott Laboratories Co. · Status since Jul 2007 | 01963104 | Cancelled Post Market | Abbott Laboratories Co. | Jul 2007 |
| W15883-CS (1 %)Warner-Lambert Canada Inc. · Status since Aug 2017 | 02240584 | Cancelled Pre Market | Warner-Lambert Canada Inc. | Aug 2017 |